Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Anti-XA Levels in Post-Cesarean Patients With BMI >35 Undergoing Enoxaparin Thromboprophylaxis With Weight Based Dosing Twice Daily Versus Fixed Dose 40 Milligrams Daily

NCT02070237 is registered in ClinicalTrials.gov with MemorialCare Health System as lead sponsor.

NCT NCT02070237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02070237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Anti-XA Levels in Post-Cesarean Patients With BMI >35 Undergoing Enoxaparin Thromboprophylaxis With Weight Based Dosing Twice Daily Versus Fixed Dose 40 Milligrams Daily
Lead sponsor
MemorialCare Health System
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2013
Completion date
March 31, 2014
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complications; cesarean section, obesity, obesity, morbid, postpartum deep phlebothrombosis, pregnancy, pulmonary embolism, venous thromboembolism